Rayonier Advanced Materials ( (RYAM) ) has released its Q2 earnings. Here is a breakdown of the information Rayonier Advanced Materials presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Rayonier Advanced Materials Inc. is a global leader in cellulose-based technologies, producing cellulose specialties, biomaterials, and products for the paper and packaging markets with operations in the U.S., Canada, and France. In its second quarter of 2025, RYAM reported net sales of $340 million but faced a significant loss from continuing operations of $366 million, largely due to a $337 million non-cash Canadian deferred tax asset write-off. The company achieved an adjusted EBITDA of $28 million, with total debt standing at $746 million. Despite these challenges, RYAM remains optimistic about its long-term strategy, aiming to achieve over $300 million in run-rate EBITDA by 2027. The company is focusing on stabilizing its operations and capturing growth opportunities in cellulose specialties and biomaterials. Management is confident in overcoming recent headwinds and is committed to executing its strategic initiatives to enhance shareholder value.

